News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
WEAVER GREGORY L
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/05/2023 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 125,000 options to buy
@ $0.662, valued at
$82.8k
|
|
| 05/16/2022 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 50,000 options to buy
@ $0.93, valued at
$46.5k
|
|
| 03/04/2022 |
4
| WEAVER GREGORY L (CFO) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Granted 228,000 options
@ $5.65, valued at
$1.3M
|
|
| 07/07/2021 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 57,084 shares
@ $6.4, valued at
$365.3k
Sold 107,497 shares
@ $5.58, valued at
$599.8k
Exercised 4,581 options to buy
@ $5.64, valued at
$25.8k
Exercised 45,000 options to buy
@ $2.38, valued at
$107.1k
Exercised 45,000 options to buy
@ $2.52, valued at
$113.4k
Exercised 70,000 options to buy
@ $1.7, valued at
$119k
|
|
| 06/24/2021 |
4
| WEAVER GREGORY L (CFO) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Bought 4,666 shares
@ $15, valued at
$70k
|
|
| 06/22/2021 |
4
| WEAVER GREGORY L (CFO) has filed a Form 4 on ATAI Life Sciences N.V.|
Txns:
| Granted 67,726 options
@ $15, valued at
$1M
|
|
| 06/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/18/2021 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 50,000 options to buy
@ $2.9, valued at
$145k
|
|
| 05/19/2020 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 70,000 options to buy
@ $1.7, valued at
$119k
|
|
| 03/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/31/2020 |
4
| WEAVER GREGORY L (CFO) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 1,733 shares
@ $3.91, valued at
$6.8k
Exercised 5,000 restricted stock units
@ $0 |
|
| 05/21/2019 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 45,000 options to buy
@ $2.52, valued at
$113.4k
|
|
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2018 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 45,000 options to buy
@ $2.38, valued at
$107.1k
|
|
| 05/15/2018 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on Egalet Corp|
Txns:
| Granted 75,000 options to buy
@ $0.6, valued at
$45k
|
|
| 03/26/2018 |
4
| WEAVER GREGORY L (CFO) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Bought 4,500 shares
@ $8.56, valued at
$38.5k
|
|
| 02/23/2018 |
4/A
| WEAVER GREGORY L (CFO) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 399,266 options to buy
@ $0 |
|
| 12/22/2017 |
4
| WEAVER GREGORY L (CFO) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 399,266 options to buy
@ $7, valued at
$2.8M
|
|
| 12/22/2017 |
3
| WEAVER GREGORY L (CFO) has filed a Form 3 on Eloxx Pharmaceuticals, Inc. |
| 06/12/2017 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on Egalet Corp|
Txns:
| Granted 58,133 options to buy
@ $2.38, valued at
$138.4k
|
|
| 05/26/2017 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 54,949 options to buy
@ $0.47, valued at
$25.8k
|
|
| 06/17/2016 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on Egalet Corp|
Txns:
| Granted 29,666 options to buy
@ $4.98, valued at
$147.7k
|
|
| 06/17/2016 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on Egalet Corp|
Txns:
| Granted 10,000 options to buy
@ $12.08, valued at
$120.8k
|
|
| 05/19/2016 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 112,190 options to buy
@ $0.263, valued at
$29.5k
|
|
| 05/14/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/01/2014 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on Egalet Corp|
Txns:
| Granted 20,000 options to buy
@ $5.7, valued at
$114k
|
|
| 06/11/2014 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on Egalet Corp|
Txns:
| Granted 667 options to buy
@ $15, valued at
$10k
|
|
| 05/08/2014 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Disposed/sold 24,510 shares
@ $0
Granted 15,000 options to buy
@ $1.22, valued at
$18.3k
|
|
| 02/07/2014 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on Egalet Corp|
Txns:
| Granted 2,083 options to buy
@ $12, valued at
$25k
|
|
| 01/21/2014 |
4
| WEAVER GREGORY L (CFO) has filed a Form 4 on Fibrocell Science, Inc.|
Txns:
| Granted 40,000 options to buy
@ $4.95, valued at
$198k
|
|
| 11/22/2013 |
4
| WEAVER GREGORY L (Director) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Bought 10,000 shares
@ $2.5785, valued at
$25.8k
|
|
| 11/20/2013 |
4
| WEAVER GREGORY L (CFO) has filed a Form 4 on Fibrocell Science, Inc.|
Txns:
| Bought 10,000 shares
@ $3.508, valued at
$35.1k
|
|
|
|
|